Accenture and Tokyo Women's Medical University to Conduct Joint Research on Potential Benefits of Artificial Intelligence for Kidney Transplant Treatment

TOKYO; Nov. 5, 2020 – Accenture (NYSE:ACN) and Tokyo Women’s Medical University (TWMU) have agreed to conduct joint research using artificial intelligence (AI) to verify and analyze kidney transplant test results, recognize early-stage kidney transplant rejection tendencies and to foresee side effects in efforts to identify more effective post-operation treatments for patients.

from News | Accenture Newsroom https://ift.tt/2TVeAvi




Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

UK to Receive Egyptian LNG Cargo

HANA Housekeeping using HANACleaner